Cover Image
市場調查報告書

生物性保存技術的全球市場:2015∼2019年

Global Biopreservation Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 339609
出版日期 內容資訊 英文 63 Pages
訂單完成後即時交付
價格
Back to Top
生物性保存技術的全球市場:2015∼2019年 Global Biopreservation Market 2015-2019
出版日期: 2015年09月09日 內容資訊: 英文 63 Pages
簡介

生物性保存技術,是以各種溫度長期間保存在自然環境外的細胞、組織,及內臟器官的功能性和完全性的流程。美國用疫苗挽救了年度300萬人的生命,不過,由於不合適的保存狀態和冷藏環境,年度有2,000萬美元疫苗被扔掉。臨床、研究,及商用採用的生物學樣品的保存變得很重要。預計全球生物性保存技術市場以2014∼2019年以年複合成長率17.06%擴大。

本報告提供全球生物性保存技術市場現狀及未來方案的相關調查、市場規模、收益預測、各地區趨勢,及主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

  • 市場概要
  • 主要供應商的產品概要

第3章 市場調查方法

第4章 簡介

第5章 概要

  • 生物性保存技術
  • 生物性保存技術方法

第6章 生物銀行的資金籌措和財政的永續性

  • 費用回收模式趨勢

第7章 生物銀行的調整性

第8章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第9章 各用途市場市場區隔

  • 生物銀行
  • 再生醫療
  • 藥物研發

第10章 各產品市場區隔

  • 設備
  • 培養基

第11章 各地區市場區隔

  • 歐洲、中東、非洲
  • 南北美洲
  • 亞太地區

第12章 推動市場的要素

第13章 推動市場的要素的影響

第14章 市場課題

第15章 促進要素與課題的影響

第16章 市場趨勢

第17章 供應商環境

  • 競爭模式
  • 市場佔有率分析:2014年
  • 其他值得注意的供應商

第18章 主要供應商分析

  • BioCision
  • BioLife Solutions
  • Thermo Fisher Scientific

第19章 附錄

第20章 Technavio的檢驗

圖表

目錄
Product Code: IRTNTR7061

About biopreservation

Biopreservation is the process of preserving the functionality and integrity of cells, tissues, and organs outside the native environment for extended storage time at different temperatures. In the US, vaccines save 3 million lives annually but because of inadequate storage and improper refrigeration, vaccines worth $20 million are wasted annually. Vaccines are of two types: live and inactivated. Based on their sensitivity and types, these vaccines are stored at different temperature. For example, inactivated vaccines are sensitive to excessive heat and freezing temperature; therefore, they are stored at 2°C to 8°C. Live vaccines such as varicella and MMRV are stored at -15°C. Similar to vaccines, biological specimens such as blood, plasma, and tumor cell lines need to be stored to remain functional. Preservation of biological samples is important as these samples are used for clinical, research, and commercial purposes.

The preservation of biosamples includes in-vitro culture, hypothermic storage, cryopreservation, and desiccation. The rising demand for storage has emerged the global biopreservation market.

Based on storage temperature, the market can be classified into five categories:

  • Room temperature (+20°C)
  • Refrigeration (+4°C)
  • Frozen (-20°C)
  • Ultra-low (-80°C)
  • Cryogenic (-196°C)

Technavio's analysts forecast the global biopreservation market to grow at a CAGR of 17.06% over the period 2014-2019.

Covered in this report

This report covers the present and future scenario of the global biopreservation market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of biopreservation storage equipment, freezing media, and other cryoware accessories.

Technavio's report, Global Biopreservation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also covers the landscape of the market and its growth prospects in the coming years. The report includes a detailed discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • BioCision
  • BioLife Solutions
  • Thermo Fisher Scientific

Other prominent vendor

  • Brooks Automation
  • Biomatrica
  • Chart MVE BioMedical
  • CRYO
  • Eppendorf North America
  • Haier Bio-Medical and Laboratory
  • Helmer Scientific
  • Panasonic Healthcare
  • So-Low Environmental Equipment
  • VWR Lab Products

Market driver

  • Growing demand for temperature-sensitive vaccines and biologicals
  • For a full, detailed list, view our report

Market Challenge

  • Reduced immunogenic potency of vaccines due to inappropriate storage conditions
  • For a full, detailed list, view our report

Market trend

  • Preserving human cells for regenerative medicines
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Overview

  • Biopreservation
  • Biopreservation methods

PART 06: Biobank funding and financial sustainability

  • Moving toward cost recovery model

PART 07: Harmonization of biobanking

PART 08: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 09: Market segmentation by application

  • Global biopreservation market for biobank
  • Global biopreservation market for regenerative medicine
  • Global biopreservation market for drug discovery

PART 10: Market segmentation by product

  • Capital equipment
  • Media

PART 11: Geographical segmentation

  • Biopreservation market in EMEA
  • Biopreservation market in Americas
  • Biopreservation market in APAC

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

  • Competitive Scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 18: Key vendor analysis

  • BioCision
  • BioLife Solutions
  • Thermo Fisher Scientific

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Different types of biopreservation methods
  • Exhibit 03: Revenue models of biobanks
  • Exhibit 04: Organizations and initiatives toward biobank harmonization
  • Exhibit 05: Global biopreservation market 2014-2019 ($ billions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Segmentation of global biopreservation market by application
  • Exhibit 08: Segmentation of global biopreservation market by application 2014
  • Exhibit 09: Global biopreservation market for biobank 2014-2019 ($ billions)
  • Exhibit 10: Global biopreservation market for regenerative medicine 2014-2019 ($ millions)
  • Exhibit 11: Global biopreservation market for drug discovery 2014-2019 ($ millions)
  • Exhibit 12: Segmentation of global biopreservation market by product 2014
  • Exhibit 13: Segmentation of global biopreservation market by geography 2014
  • Exhibit 14: Biopreservation market in EMEA 2014-2019 ($ millions)
  • Exhibit 15: Biopreservation market in Americas 2014-2019 ($ millions)
  • Exhibit 16: Biopreservation market in APAC 2014-2019 ($ millions)
  • Exhibit 17: Cost-effectiveness of viable and functional cells with storage time and transportation
  • Exhibit 18: Impact of drivers
  • Exhibit 19: Impact of drivers and challenges
  • Exhibit 20: BioCision: Key takeaways
  • Exhibit 21: BioLife Solutions: Key takeaways
  • Exhibit 22: Thermo Fisher Scientific: Key takeaways
  • Exhibit 23: BioCision: Product segmentation
  • Exhibit 24: Business segmentation by revenue 2014
  • Exhibit 25: Business segmentation by revenue 2014
  • Exhibit 26: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 27: Geography segmentation by revenue 2014
Back to Top